We are live on
!
Find out more
BCM
Boxer Capital Management Portfolio holdings
AUM
$762M
1-Year Est. Return
1,125.36%
This Fund
S&P 500
This Quarter
Est. Return
+54.02%
1 Year Est. Return
+1,125.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$762M
AUM Growth
+$305M
(+67%)
Cap. Flow
+$141M
Cap. Flow
% of AUM
18.47%
Top 10 Holdings %
Top 10 Hldgs %
63.32%
Holding
56
New
11
Increased
13
Reduced
3
Closed
2
Top Buys
| 1 |
Vaxcyte
PCVX
|
+$17.6M |
| 2 |
Corvus Pharmaceuticals
CRVS
|
+$17.6M |
| 3 |
Revolution Medicines
RVMD
|
+$10.1M |
| 4 |
Vir Biotechnology
VIR
|
+$9.89M |
| 5 |
Corcept Therapeutics
CORT
|
+$9.35M |
Top Sells
| 1 |
CDTX
Cidara Therapeutics
CDTX
|
+$11.7M |
| 2 |
PepGen
PEPG
|
+$568K |
| 3 |
HELP
Cybin Inc
HELP
|
+$485K |
| 4 |
NUVB.WS
Nuvation Bio Inc Warrants
NUVB.WS
|
+$88K |
| 5 |
Inovio Pharmaceuticals
INO
|
+$82.3K |
Sector Composition
| 1 | Healthcare | 99.69% |
| 2 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tango Therapeutics
TNGX
$4.93B
| $228M | 29.87% |
10,876,219
| – | – |
|
2
Kodiak Sciences
KOD
$2.65B
| $51.9M | 6.81% |
1,361,000
+225,000
| +20% | +$5.81M |
|
|
3
Revolution Medicines
RVMD
$39.2B
| $48.6M | 6.38% |
500,000
+100,000
| +25% | +$10.1M |
|
4
Kymera Therapeutics
KYMR
$9.39B
| $27.4M | 3.6% |
329,100
| – | – |
|
5
Celcuity
CELC
$4.46B
| $25.7M | 3.37% |
225,000
| – | – |
|
6
Surrozen
SRZN
$253M
| $22.3M | 2.93% |
766,318
+350,168
| +84% | +$8.39M |
|
|
ABVX
7
Abivax
ABVX
$11.9B
| $22.3M | 2.92% |
200,000
+75,000
| +60% | +$8.88M |
|
|
TERN
8
DELISTED
Terns Pharmaceuticals
TERN
| $19.8M | 2.6% |
375,000
| – | – |
|
|
9
Vaxcyte
PCVX
$8.19B
| $18.9M | 2.48% |
+325,000
| New | +$17.6M |
|
10
Capricor Therapeutics
CAPR
$1.18B
| $17.9M | 2.35% |
590,000
+265,000
| +82% | +$7.06M |
|
11
Protagonist Therapeutics
PTGX
$8.71B
| $17.9M | 2.35% |
170,000
| – | – |
|
|
12
Vir Biotechnology
VIR
$1.62B
| $16.7M | 2.2% |
1,866,000
+1,241,000
| +199% | +$9.89M |
|
|
13
Corvus Pharmaceuticals
CRVS
$1.25B
| $16.1M | 2.11% |
+1,100,000
| New | +$17.6M |
|
14
Praxis Precision Medicines
PRAX
$8.88B
| $15M | 1.97% |
46,457
| – | – |
|
15
PTC Therapeutics
PTCT
$6.54B
| $13.6M | 1.79% |
200,000
| – | – |
|
16
Precigen
PGEN
$1.83B
| $13.5M | 1.78% |
3,500,000
+2,125,000
| +155% | +$8.72M |
|
|
DFTX
17
Definium Therapeutics
DFTX
$6.06B
| $11.3M | 1.49% |
598,500
| – | – |
|
18
Amylyx Pharmaceuticals
AMLX
$1.98B
| $11.1M | 1.46% |
800,000
| – | – |
|
19
uniQure
QURE
$2.82B
| $10.8M | 1.42% |
662,000
+372,000
| +128% | +$7.53M |
|
|
IRD
20
Opus Genetics
IRD
$287M
| $10.2M | 1.34% |
+2,250,000
| New | +$7.78M |
|
|
21
Corcept Therapeutics
CORT
$9.62B
| $10.1M | 1.32% |
+250,000
| New | +$9.35M |
|
22
UroGen Pharma
URGN
$1.94B
| $8.99M | 1.18% |
500,000
| – | – |
|
23
Replimune Group
REPL
$813M
| $8.99M | 1.18% |
1,175,000
+425,000
| +57% | +$3.25M |
|
24
Cogent Biosciences
COGT
$6.72B
| $8.66M | 1.14% |
225,000
| – | – |
|
25
Palisade Bio
PALI
$353M
| $8.4M | 1.1% |
4,799,875
| – | – |
|
Similar funds
FTF
FPCP
CFS
PMWMG
SC
FCA
CCIP
GWM